GGrantIndex
Sort

40,608 grants matching prostate cancer

Diet change among prostate cancer patients under expectant management

$457,057
James Marshall · Roswell Park Cancer Institute Corp · R01 · FY2015 · CA

Genomic Imprinting in Cancer

$456,994
Andrew P Feinberg · Johns Hopkins University · R01 · FY2008 · CA

5 ALPHA REDUCTASE GENOTYPE, RACE PROSTATE CANCER RISK

$456,934
University Of Southern California · R01 · FY2000 · CA

Glucocorticoid Receptor Transcriptional Activity and the Evolution of Enzalutamide-Resistant CRPC

$456,918
Russell Z Szmulewitz · Northwestern University At Chicago · P50 · FY2018 · CA

Project 3: Defining the appropriate context for targeting kinase signaling in combination with androgen receptor blockade to enhance therapeutic response in metastatic prostate cancer

$456,888
Brett Stewart Carver · Sloan-Kettering Inst Can Research · U54 · FY2019 · CA

MRI of tumor-infiltrating lymphocytes using MRI-cytometry

$456,808
Junzhong Xu · Vanderbilt University Medical Center · R01 · FY2023 · CA

EDRN Biomarker Reference Laboratory

$456,743
National Cancer Institute · Y01 · FY2012 · CA

Instrumental Variable Methods for Censored Cost Data and an Application in Prosta

$456,707
Anirban Basu · University Of Washington · R01 · FY2011 · CA

Molecular Targets for Cancer Detection and Treatment

$456,641
William George Nelson · Johns Hopkins University · T32 · FY2006 · CA

Ethnicity & Determinants of QoL Following PCa Treatment

$456,576
Frank J Penedo · University Of Miami Coral Gables · R01 · FY2008 · CA

ST Louis-Cape Girardeau CCOP

$456,567
Bethany Sleckman · St. John'S Mercy Medical Center · U10 · FY2008 · CA

Vitamin D Status and Prostate Cancer

$456,550
Purdue University West Lafayette · R01 · FY2005 · CA

Comparative Oncology Program

$456,384
Chand Khanna · Division Of Basic Sciences - Nci · ZIG · FY2012 · CA

Cyclic Peptide Nanoparticles Based Dual-drug Delivery to Treat Prostate Cancer

$456,353
Mingjun Zhang · Ohio State University · R01 · FY2018 · CA

Base Excision Repair Deficiency as a Risk Modifier in BRCA2 Associated Cancer

$456,353
Shailja Pathania · University Of Massachusetts Boston · R15 · FY2019 · CA

High speed automated intraoperative microscopy of the prostate circumference to ensure tumor-free margins in radical prostatectomy

$456,329
Jonathan Quincy Brown · Tulane University Of Louisiana · R01 · FY2018 · CA

5 ALPHA REDUCTASE GENOTYPE, RACE PROSTATE CANCER RISK

$456,302
University Of Southern California · R01 · FY2003 · CA

TISSUE PROTEIN PROFILING/IMAGING SHARED RESOURCES

$456,289
Richard M Caprioli · Vanderbilt University · P30 · FY2008 · CA

NGF recruits nerve fibers to reprogram an immunosuppressive microenvironment in melanoma

$456,286
Xiao-Fan Wang · Duke University · R01 · FY2020 · CA

Molecular Genetic Dissection of Photoreceptor Function

$456,269
William L Pak · Purdue University · R01 · FY2007 · EY

Biopsy Tracking and MRI Fusion to Enhance Imaging of Cancer Within the Prostate

$456,245
Leonard Stephen Marks · University Of California Los Angeles · R01 · FY2012 · CA

New Award for SBIR Topic 103: Contractor: Detroit R&D: Contract No. TBD; route t

$456,245
Detroit R & D, Inc. · N01 · FY2009 · ES

Defining the role of macropinocytosis in solid tumor growth and therapeutic resistance

$456,227
Aimee L Edinger · University Of California-Irvine · R01 · FY2024 · CA

GONADOTROPIN-RELEASING HORMONE ACTION

$456,140
Oregon Health And Science University · R37 · FY2001 · HD

Enhanced imaging and treatment of aggressive subtypes of prostate cancer

$456,081
Martin G Pomper · Johns Hopkins University · R01 · FY2023 · CA